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Introduction
Neuronal Ceroid Lipofuscinoses (NCLs) are the 
most common group of rare autosomal recessive 
neurodegenerative disorders of childhood. NCL are 
histologically characterized by the building up of 
autofluorescent pigments within lysosomes. Among the 
NCLs, the juvenile CLN3 disease,1, 2 also known as juvenile 
NCL (JNCL)3 or Batten disease,4 is the most frequent. 
Increasing visual failure, seizures, motor and cognitive 
skill reduction, and early death are characteristic of 
JNCL.2 In more than 80% of patients with CLN3 deficient 
cells there is a 1.02 kb genomic DNA deletion in the CLN3 
gene (CLN3) that predicts a non-functional protein.2 The 
CLN3-encoded protein (CLN3) is a highly conserved, 
multi-pass transmembrane glycoprotein that is confined 
to endosomes and lysosomes,5,6 but its precise cell role is 
still unknown. Studies in yeast have reported that BTN1, 
which encodes the ortholog of CLN3, is involved in the 
regulation of the vacuolar pH7-9 and the phospholipid 
contents of mitochondrial and vacuolar membranes.10 
It was reported that in yeast, BTN2/CLN3 expression is 
up-regulated upon deletion of BTN1 the yeast ortholog of 
Hook1, a retromer accessory protein involved in retrieval 
of specific cargo from late endosomes to Golgi.11,12 Further 
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Abstract
Background: Juvenile neuronal ceroid lipofuscinosis (JNCL), one of the most frequent forms of the NCL 
storage diseases, is known to be caused by loss-of-function mutations in ceroid-lipofuscinosis neuronal 
protein 3 (CLN3), but its cell function has not been fully elucidated. We previously reported increased 
lysosomal pH in CLN3 deficient cells. In the present study, we analysed the consequences of this effect 
in the endo-lysosomal pathways in CLN3 cells.
Methods: The present study investigated different endo-lysosomal pathways in control, CLN2, CLN3 
human skin fibroblasts under high and low proteolysis conditions. Cell surface biotinylation after EGF 
(2 ng/mL) stimulation, EGF phosphorylation (Tyr-845), retromer and cation-independent mannose-6-
phosphate receptor (CI-MPR) levels and stability, EGF degradation pathways and cathepsin L and D 
levels were analysed by western blots. Caveolae mediated endocytosis was analysed by flow cytometry. 
CIMPR subcellular localization was ascertained by immunocytochemistry, confocal microscopy and 
further image analysis.
Results: Whereas caveolae-mediated endocytosis was not affected in CLN3 cells, clathrin-mediated 
epidermal growth factor (EGF) internalization was reduced, along with EGF receptor (EGFR) 
phosphorylation. In addition, cell surface EGFR levels and recycling to the cell membrane were 
increased. EGFR lysosomal degradation was impaired and our results suggest that the receptor was 
diverted to proteasomal degradation. We also analysed the machinery responsible for lysosomal 
hydrolase transport to the lysosome and found increased stability of CIMPR, a major receptor implicated 
in the transport of hydrolases. The subcellular distribution of the CI-MPR was also altered in CLN3 cells, 
since it accumulated within the Trans-Golgi network (TGN) and did not progress into the lysosomes. In 
addition, we found a reduced turnover of retromer subunits, a complex that retrieves the CI-MPR from 
endosomes to the TGN. Finally and as a possible consequence of these alterations in lysosomal enzyme 
transport, cathepsin L and D maturation were found suppressed in CLN3 cells. 
Conclusion: Altogether, these results point to increased lisosomal pH as a pivotal event causing various 
alterations in intracellular traffic associated to the development of JNCL disease.
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studies in yeast concluded that BTN1 regulates retrograde 
sorting by mediating vesicle fusion through SNARE 
protein phosphorylation and assembly, which could be 
altered in JNCL.13
In mammalian cells, a role for CLN3 in endocytic 
trafficking has been proposed.14-17 Luiro et al showed that 
CLN3 overexpression in HeLa cells induces aggregation 
of Hook1, causing its dissociation from the microtubules 
in endosomal fusion events.14 They linked in CLN3 
fibroblasts the observed abnormalities to a delay in the 
lysosomal delivery of low-density lipoprotein and to 
increased recycling rates of transferrin.14
Other studies using mammalian cells have also indicated 
that CLN3 is directly implicated in the regulation of 
lysosomal pH18 or in the delivery of lysosomal enzymes.19,20
Soluble acid hydrolases, once modified with mannose 
6-phosphate residues in the Golgi, are commonly 
recognized by mannose 6-phosphate receptors and 
then transported to the endo/lysosomal system.21 For 
example, two of the main lysosomal cathepsins, D and 
L, are transported by the cation-independent mannose 
6-phosphate receptor (CI-MPR).22 Cathepsin D is known 
to degrade ATP synthase subunit c, which typically 
accumulates in CLN3 deficient cells.23 In lysosomes, 
cathepsin L has been found to cleave CLN7p, a protein 
deficient in a variant of the late-infantile NCL.24 Cathepsin 
L has also been localized in secretory vesicles containing 
neuropeptides and found to play an essential role in 
neurotransmitter production.25
Our previous studies indicated that lysosomal pH was 
increased in isolated cells from JNCL patients, resulting 
in reduced fusion of autophagosomes with lysosomes.26 In 
the present study, we further examined the consequences 
of increased pH in CLN3 cells in other lysosomal related 
processes. Throughout the text, CLN3-deficient cells 
will be referred to as CLN3 cells. Cells carrying the tpp1 
mutation (CLN2 cells) have been used as control cells 
along with non-mutated cells (control cells). We report in 
these cells alterations in receptor-mediated endocytosis 
and in delivery of lysosomal cathepsins to lysosomes. Our 
data are consistent with the idea that increased lysosomal 
pH plays a central role in determining the phenotype of 
cells from JNCL patients.
Results
CLN3 cells have increased EGFR recycling 
To examine receptor-mediated endocytosis, we analysed 
the phosphorylation state of the EGFR by Western blot 
and the rate of ligand endocytosis using EGF bound 
to Alexa Fluor 488 (AF488-EGF) by flow cytometry. 
To avoid possible aging effects, all experiments were 
done comparing cells at a similar passage number 
(10–14) in the cell culture. Upon ligand binding, EGFR 
phosphorylation increases at 5, 10 and 15 min in CLN3 
cells as compared to control cells (Figure 1A). On the 
contrary, internalization of EGF was similar in CLN3 
and control cells (Figure 1B, left panel). Flow cytometry 
analysis of internalized BODIPY FL C5-Ceramide, a 
specific marker of caveolae-mediated endocytosis,27 shows 
that this type of internalization was not altered either in 
CLN3 fibroblasts as compared to controls (Figure 1B, 
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Figure 1. Alterations of EGF endocytosis in CLN3 cells. (A) Control and CLN3 fibroblasts were incubated with EGF (100 ng/mL) in high proteolysis medium 
for the indicated time periods. A representative blot of total cell extracts analysed with antibodies that recognize phosphorylated (Tyr845) EGFR and actin is 
shown. Bands were quantified and the ratios of EGFR to actin are shown below. (B) Comparison of EGF (left panel) or BODIPY FL C5-Ceramide (right panel) 
internalization in control, CLN2 and CLN3 fibroblasts incubated at 37 ºC with AF488-EGF (200 ng/mL) or BODIPY FL C5-Ceramide (0.5 μM), respectively, for 
the indicated times. After washing, measurements were carried out by flow cytometry as described in Materials and Methods and are shown as percentage of 
fluorescently labelled cells. (C) Exponentially growing control, CLN2 and CLN3 fibroblasts incubated in high proteolysis medium were surface biotinylated, 
stimulated with EGF (2 ng/mL) and treated with reduced glutathione as explained in Materials and Methods. Samples were pulled-down with NeutrAvidin 
agarose-beads and subsequently analyzed by immunoblotting using anti-EGFR and, as an internal control, anti-TfR antibodies. Representative blots are shown 
and EGFR bands from three independent experiments similar to those shown were densitometred and normalized to the corresponding transferrin bands. Data 
from three independent experiments are expressed in % relative to cells at time 0 min. All results are the mean ± SD from three separate experiments, with 
triplicated measurements, and stars indicate statistically significant differences from control values at each time point.
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is likely altered, as flow cytometry analysis revealed that 
binding to cholera toxin B (ChTxB), which binds to cell 
surface GM1 gangliosides,28 is severely impaired in CLN3 
fibroblasts (Figure S1).
Next, we examined if EGFR recycling was altered in 
CLN3 fibroblasts in comparison to control and CLN2 
fibroblasts by cell surface protein biotinylation, in non-
treated cells (lane 1) and in cells treated with EGF at low (2 
ng/mL) concentration and reduced glutathione (50 mM); 
at such low EGF concentration, most of the receptor is 
recycled to the cell membrane.29 Internalized levels of 
biotinylated EGFR did not change among CLN3, CLN2, 
and control fibroblasts (lanes 1 and 2 in Figure 1C), in 
agreement with the observed similar EGF endocytosis. 
After subsequent treatment with EGF (2 ng/mL) and with 
reduced glutathione (50 mM), EGFR levels decreased in 
CLN3 fibroblasts as compared to cells not treated with 
activated glutathione, but the corresponding levels did 
not change in control or CLN2 fibroblasts (lanes 3 and 
4 in Figure 1C). This indicates that EGFR recycling was 
increased in CLN3 fibroblasts. Also, the comparison of 
biotinylated EGFR relative to transferrin levels in control 
versus CLN3 fibroblasts (lane 1) indicates, as expected, 
that cell surface levels of EGFR are increased in fibroblasts 
from JNCL patients.
Lysosomal degradation of EGFR is delayed and the 
receptor is diverted towards the proteasomal pathway 
in CLN3 fibroblasts
To further examine the EGFR endocytic pathway upon 
internalization, receptor levels were analysed by Western 
blot after incubation with EGF (100 ng/mL). At this high 
concentration of ligand, 90 % of the receptor is headed 
towards degradation.29 Ligand-induced degradation of 
EGFR was significantly delayed in the CLN3 fibroblasts 
as compared to their respective controls at all-time 
points (Figure 2A). As an increased lysosomal pH could 
prevent the receptor from being degraded in lysosomes, 
we examined the possibility that EGFR could undergo 
proteasomal degradation. Indeed, proteasome inhibition 
has also been shown to attenuate ligand-induced 
degradation of EGFR in HeLa cells.30 We thus analysed 
the relative contribution of lysosomal and proteasomal 
degradation pathways to degradation of EGFR in CLN3 
cells. Inhibitors were added 4 h prior to EGF (100 ng/
mL) treatment, and EGFR degradation was analysed by 
Western blot for 1 additional hour in the presence of the 
inhibitors and in high proteolysis medium to maximize 
degradation. In the presence of the proteasome inhibitor 
lactacystin, the difference in EGFR levels between CLN3 
cells and control cells was increased by 45% as compared 
to the absence of inhibitors, but not in CLN2 cells (Figure 
2B and not shown). On the contrary, in the presence of the 
lysosomal inhibitors NH4Cl plus leupeptin the difference 
in EGFR levels decreased by 55 % when compared with 
absence of inhibitors (Figure 2B). These results suggest 
that proteasome degradation of EGFR is increased in 
CLN3 fibroblasts, possibly as a compensatory mechanism 
for the impaired lysosomal degradation in these cells.
The observed variable steady-state EGFR levels in 
control and in CLN3 cells should not be affecting the 
described tendencies as similar results were obtained in 
cells with different EGFR levels (data not shown).
The stability of the CI-MPR and of the retromer 
subunits is increased in CLN3 fibroblasts under high 
proteolysis conditions
Next, we examined levels and turnover in high and 
Figure 2. In CLN3 fibroblasts, EGFR degradation is diverted from the lysosomal to a proteasomal pathway. (A) Control and CLN3 fibroblasts were incubated 
for 60 min with EGF (100 ng/mL), and total extracts were analyzed by Western blot. Representative blots and quantification of EGFR levels by densitometry 
are shown. Data in the histogram are shown in percentage relative to time 0. Stars indicate statistically significant differences from control values at each 
time point. (B) Control (CTR) and CLN3 fibroblasts were treated with EGF and with the inhibitors where indicated as described in the materials and methods 
section. Total extracts were immunoblotted with anti-EGFR and, as a loading control, anti-actin. A representative blot is shown. Bands corresponding to EGFR 
were quantified by densitometry and the ratios of EGFR to actin were plotted on the right. Stars indicate statistically significant differences in control and CLN3 
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low proteolysis media of the CI-MPR, a major receptor 
of soluble hydrolases that shuttles from the TGN to 
endosomes. Different medium conditions were used 
in these experiments for each cell type, as we wanted 
to observe differences under stressed (high proteolysis, 
H) and non-stressed lysosomal enzyme transport (low 
proteolysis, L). In the presence of cycloheximide (CHX), 
CI-MPR stability was found increased in CLN3 fibroblasts 
compared to controls under both conditions (Figure 3A). 
To analyze if this was due to CI-MPR missorting, we also 
analyzed the levels of retromer subunits because retromer 
mediates endosome-to-TGN retrieval of the CI-MPR.31,32 
Retromer is a pentameric complex which includes two 
sorting nexin family members (typically, SNX1 and 
SNX2), that curve the endosomal membrane, and three 
additional subunits, Vps26, Vps 29 and Vps 35, which 
constitute the complex core and determine cargo sorting.33 
We found that the stability of retromer subunits Vps26 
and Vps35 (Figure 3B) and SNX1 and SNX2 (Figure 3C) 
are increased in high and low proteolysis media in CLN3 
fibroblasts. The increased stability of retromer under the 
studied conditions suggests impairment of endosome-to-
TGN retrieval and possible alterations in the delivery of 
lysosomal enzymes.
CI-MPR accumulates in TGN in CLN3 fibroblasts
To explain the reduced turnover of the CI-MPR (along 
with retromer), we hypothesized that cycling of CI-MPR 
between TGN and early endosomes might be affected in 
the NCL cells. Thus, we compared the localization of CI-
MPR with that of the TGN-resident protein TGN4634 by 
confocal microscopy. Both are transmembrane proteins 
that cycle back and forth from the TGN to the early 
endosomes,35 although most of TGN46 is maintained at 
the TGN at steady state, similarly to the CI-MPR.36,37 In 
CLN3 fibroblasts, CI-MPR colocalized with TGN46 in 
tubular TGN-like structures (Figure 4). According to our 
results CI-MPR would not function as a proper enzyme 
shuttle as it would not leave the TGN. 
Processing of procathepsin L and D into cathepsin L 
and D is abrogated in CLN3 fibroblasts
Accumulation of CI-MPR in TGN could affect the transport 
of acid hydrolases to the lysosome. Cathepsins L and D 
have been shown to be shuttled to the lysosomes mainly 
by CI-MPR.22 Therefore, we examined the processing of 
procathepsin L and D to their mature forms. Fibroblasts 
were cultured in high or low proteolysis medium as we 
wanted to observe differences under stressed (High 
proteolysis) and non-stressed lysosomal enzyme transport 
(Low proteolysis). Levels of procathepsin and cathepsin 
L and D were analysed by Western blot. We found that 
procathepsin L was not converted into cathepsin L in 
CLN3 fibroblasts (Figure 5). Processing of procathepsin 
D into cathepsin D was also affected in CLN 3 fibroblasts 
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Figure 3. Increased stability of the CI-MPR and retromer subunits in CLN3 fibroblasts. Fibroblasts were incubated under high (H) or low (L) proteolysis 
conditions in the presence of cycloheximide (CHX, 100 μg/mL for 6 h). Total extracts were immunoblotted with the following antibodies: (A) anti-CI-MPR, (B) 
anti-hVps35 and anti-hVps26 and (C) anti-SNX1 and anti-SNX2. Anti-actin was used as a loading control. The bands that correspond to the analyzed proteins 
were quantified by densitometry and normalized to actin. Representative gels are shown and the histograms depict the corresponding protein/actin ratios. Stars 
indicate statistically significant differences between cycloheximide-treated and untreated fibroblasts.
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5). These results reflect the consequences of the shown 
alterations in the cell machinery responsible for TGN to 
endosome communication.
Discussion
In a previous report, we found that CLN3 cells, as opposed 
to CLN2 cells, had an increase of 0.5 units in lysosomal 
pH over normal (wild type) cells.26 The current study, 
using fibroblasts derived from Juvenile CLN3 patients 
(called CLN3 fibroblasts), analyzes the potential effects of 
this increased pH in EGFR traffic and lysosomal enzyme 
transport. EGFR/ligand dissociation and dissociation of 
the transported lysosomal enzymes from CI-MPR are 
both dependent on pH.29,38 In this study, we conclude that 
EGFR degradation is impaired as a consequence of steady 
Figure 4. In CLN3 fibroblasts, CI-MPR accumulates in the TGN. Representative fluorescence microscopy images of control and CLN3 fibroblasts incubated 
at 37ºC under high proteolysis conditions in the presence of lysosomal inhibitors, fixed, and probed with anti-CI-MPR and anti-TGN46. Cells were examined 
by confocal microscope. 
Figure 5. Processing of procathepsin L and D into the corresponding 
mature forms is impaired in CLN3 fibroblasts. Fibroblasts were incubated 
under high (H) or low (L) proteolysis conditions in the presence of 
cycloheximide (CHX, 100 μg/ml for 6 h). Total extracts were immunoblotted 
with antibodies recognizing the precursor and mature forms of cathepsin D 
and cathepsin L, using actin as a loading control.


































recycling of the receptor to the cell surface. Furthermore, 
our results suggest that CI-MPR, the major lysosomal 
enzyme receptor, is also constantly recycled back from 
endosomes to the TGN, and, therefore, enzyme transport 
to lysosomes is altered.
EGFR auto phosphorylation, that occurs immediately 
after ligand binding, and is required for endocytic 
processing of the EGFR/ligand complex,39 was increased 
in CLN3 fibroblasts. Nevertheless, receptor-mediated 
endocytosis, that occurs immediately thereafter, was not 
affected. Once the EGFR/ligand complex arrives to the 
early endosomes, it can be recycled to the cell membrane 
or delivered to late endosomes and lysosomes for 
degradation. In HeLa cells, only 30% of the internalized 
EGFR is degraded at low (1.5 ng/mL) EGF concentrations, 
while most of it is recycled. However, at high (100 ng/
mL) EGF concentrations, approximately 90% of the 
internalized receptor is degraded.31 In CLN3 cells, we 
found both increased recycling and impaired degradation 
of the EGFR at low and high concentrations of EGF, 
respectively. The increase in recycling could explain the 
increased amounts of EGFR at the cell membrane as well 
as the increase in receptor phosphorylation in the CLN3 
cells. The decreased EGFR degradation could account for 
its higher steady state levels. Our results indicate that the 
internalized EGFR is not transported to lysosomes but is 
recycled back to the cell membrane in CLN3 cells.
Our results show that the CI-MPR – as well as subunits 
of the retromer complex, which mediates CI-MPR 
retrieval from endosomes to TGN – is more stable in 
CLN3 fibroblasts. The increased stability of CI-MPR and 
retromer levels might be a possible cell compensatory 
mechanism to try to preserve their altered functions. In 
accordance with our results, a role of the CLN3p in CI-
MPR traffic from the TGN has been already shown in 
HeLa cells with a transfected chimaeric CI-MPR reporter 
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(CD8-CI-MPR) by Metcalf et al.20 These authors found 
that ablation of CLN3p caused a 50% reduction in exit 
of the CI-MPR reporter from the TGN. In accordance 
to our findings concerning CI-MPR stability, Qureshi 
et al40 showed in HeLa cells transfected with a plasmid 
expressing the a c.A959G mutant CLN5p, which has been 
physically and functionally related with the CLN3p,41,42 
that mutant CLN5p was deficiently glycosylated and 
was abnormally detained in the endoplasmic reticulum 
resulting in reduced delivery to the endolysosomal 
compartment. Most of ours and the previously published 
work agree with the notion that impaired CLN3 function 
is related to altered trafficking and localization of CI-
MPR.
A failure in CI-MPR localization, as well as the inability 
to deliver its cargo to the endo-lysosomal compartment 
due to changes in pH, could have a deep impact in 
delivery of lysosomal enzymes, such as cathepsins, whose 
precursors are transported by the CI-MPR.22 Thus, Arighi 
et al observed that depletion of hVps26 by siRNA causes 
CI-MPR lysosomal degradation and reduced cathepsin D 
levels in HeLa cells.31 Similarly, Seaman showed a defect in 
cathepsin D maturation in HeLa cells after mVPS26 knock 
down in spite of seeing no effect in CI-MPR turnover.32 
The study from Qureshi et al also showed a significant 
decrease in procathepsin D to cathepsin D conversion.40 
A past study in Drosophila cells shows that retromer is 
needed for the right delivery of cathepsin L to lysosomes, 
but independently of the Drosophila homolog of the CI-
MPR43. Our results are consistent with these reports as 
we found mislocalized CI-MPR and deficient cathepsin 
D maturation in CLN3 cells. A recent study by Carcel-
Trullols et al further showed that in Baby Hamster Kidney 
cells,  stably  expressing  myc-tagged  human  CLN3, activity 
of cathepsin D decreased as CLN3 expression increased 
under    hyperosmolar    conditions.44 Several studies in 
animal models have indicated that there are close ties 
between maturation and activity of cathepsin D and NCL 
disease.45-47 In addition, a reduction in the maturation 
of cathepsin D, which is known to degrade the subunit 
c of the ATP synthase, could explain its accumulation, 
a distinctive marker of the NCL phenotype.23 According 
to our results, the observed alterations in lysosomal 
enzyme transport in CLN3 cells are also reflected in a 
completely abrogated processing of procathepsin L into 
cathepsin L in CLN3 cells. Procathepsin L is mainly 
transported by the CI-MPR, although in neurons, 
SORLA/SORL1, an APP receptor which dysfunction is 
implicated in Alzheimer’s disease, has also been involved 
in this process.48 Cathepsin L has been postulated as a 
central nervous system neuroprotease that participates 
in peptide neurotransmission and in neurodegenerative 
diseases, and expression of human cathepsin L has been 
found to prevent neuronal cell death and consequent 
neurodegeneration in cells of the cerebral cortex and in 
Purkinje cells of the cerebellum.49,50 An animal model 
with a combined deficiency in cathepsins B and L resulted 
in early-onset neurodegeneration in mice reminiscent of 
NCL in humans.50 Other reports suggest that cathepsin 
L may be linked to Parkinsonian neurodegeneration by 
means of 6-hydroxydopamine induced apoptosis.51 Thus, 
the lack of procathepsin L maturation could be the linkage 
between lysosomal alterations and neurodegeneration.
In conclusion, the results presented in this study show 
that in juvenile CLN3 disease, increased lysosomal pH 
might be responsible for the reported alterations in EGFR 
recycling and degradation. Along with these alterations 
the showed CI-MPR mislocalization likely plays a very 
important role in the alterations of cathepsin L and D 
maturation that may critically affect JNCL and other 
types of related NCL diseases. 
Materials and Methods
Materials 
Minimum essential medium (MEM), human insulin, 
3-methyladenine, NH4Cl,  PMSF, cycloheximide, EDTA, 
streptavidin, L-glutathione (reduced), anti-tubulin 
antibody and horseradish-peroxidase labelled secondary 
antibodies were purchased from Sigma Chemical Co. EZ-
Link Sulfo-NHS-SS-Biotin and Biotinylation Kits (NHS-
SS-Biotin) were purchased from Thermo Fisher Scientific. 
MEM amino acids 50x, MEM non-essential amino 
acids 100x, penicillin, MEM vitamins, streptomycin, 
foetal bovine serum and recombinant human EGF 
(PHG0311) were supplied by Life Technologies. 
Leupeptin and lactacystin were acquired from Peptide 
Institute, Inc. Phosphospecific antibodies that recognize 
phosphorylated (Tyr-845)-EGFR (#6963) were purchased 
from Cell Signalling. Specific antibodies that recognize 
total EGFR (ab2430), used in western blot experiments, 
and CI-MPR (ab2733) and TGN46 (ab16052), used in the 
immunofluorescence experiments, were purchased from 
Abcam. Rabbit polyclonal antibodies to human retromer 
subunits52 have been described previously. A polyclonal 
anti-CI-MPR antibody was obtained as a gift from Dr. 
B. Hoflack. AF488-EGF (E-13345), AF488-ChtxB (C-
34775), Alexa Fluor® 488 goat anti-mouse IgG, IgM 
(H+L) (A-10667) and Alexa Fluor® 546 goat anti-rabbit 
IgG (H+L) (A-11010) were purchased from Molecular 
Probes-Life Technologies. Other reagents, such as H2O2, 
Bovine Serum Albumin (BSA), trichloroacetic acid 
(TCA), and Purpald (4-amino-3-hydrazino-5-mercapto-
1,2,4-triazole-3-thiol), were of the best analytical quality 
available.
Cell Culture
Control cells, CLN2, CLN3 human skin fibroblasts were 
obtained from the Coriell Institute for Medical Research 
(Camden, NJ, USA). Conditions for cell growth, cell 
viability and growth curves as well as high and low 
proteolysis conditions were described previously.26
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Flow Cytometry
Determination by flow cytometry of clathrin-mediated 
endocytosis was performed essentially as described 
earlier53 and caveolae-mediated endocytosis was 
performed as a modification of an existing protocol.54 
Subconfluent fibroblasts were incubated at 37°C under 
high proteolysis conditions to maximize internalization 
for the indicated times in the presence of AF488-EGF 
(200 ng/mL) or BODIPY FL C5-Ceramide (0.5 µM). 
Cells were then washed with cold PBS at 4°C and about 
5×105 cells were immediately analyzed by flow cytometry 
(FACSCalibur flow cytometer from BD Biosciences). Cells 
were analyzed at excitation and emission wavelengths 
of 495 and 519 nm, respectively, for the AF488-EGF 
experiment, and at 505 nm and 620, respectively, for 
the BODIPY FL C5-Ceramide determination. Mean 
fluorescence values were obtained, and the % of positive 
cells was calculated for every experimental condition.
To determine the binding of ChTxB and GM1 cell 
membrane contents, cells were incubated in a buffer 
containing ChTxB bound to Alexa Fluor-488 (AF488-
ChtxB) (1 µg/mL) in cold PBS containing sodium azide 
(0.1 %) at 4°C for one minute to prevent internalization, 
and then cells were washed three times in cold PBS 
containing sodium azide (0.1%) at 4°C. About 5×105 
cells were immediately analyzed by flow cytometry 
(FACSCalibur flow cytometer, from BD Biosciences) at 
excitation and emission wavelengths of 495 and 519 nm, 
respectively, and mean fluorescence values were plotted.
Protein Determination and Western Blot
These procedures have been already described.55 To 
determine protein degradation, cells were incubated for 
6 hours with 100 µg/mL cycloheximide. All blots were 
developed using Lumi-Light Western Blotting Substrate 
and protein bands were quantified by densitometric 
analysis (Image Quant ECL, GE Healthcare). 
For analysis of EGFR phosphorylation by immunoblot, 
cells were collected and lysed in lysis buffer (1% 
Nonidet-P40, 0.5% sodium deoxycholate, 0.1% SDS, 50 
mM Tris-HCl, 15% glycerol, 150 mM NaCl, 2 mM Na3VO4, 
100 mM NaF, 20 mM Na4P2O7, pH 7.4, containing 1 mM 
PMSF and 100 µM leupeptin,) at 4°C. Immunoblots 
were probed against phospho-specific EGFR and actin 
antibodies.
For semiquantitative determination of EGFR 
degradation, confluent fibroblasts were incubated at 
37°C under high proteolysis conditions with or without 
EGF (100 ng/mL) for 15, 30 and 60 minutes. To inhibit 
protein degradation, cells were incubated 4 h before the 
addition of EGF with the lysosomal inhibitors NH4Cl (20 
mM) and leupeptin (100 µM), or with the proteasomal 
inhibitor lactacystin (30 µM). Cells were then washed 
with cold PBS and homogenized in RIPA buffer (150 mM 
NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% 
SDS, 50 mM Tris, pH 8.0) containing 0.1 mM leupeptin 
and 1 mM PMSF. Extracts were centrifuged at 12,000 g 
for 10 minutes at 4ºC and the supernatants were collected 
for Western blot. Lysates (50 µg protein) were analyzed 
on 15% SDS-PAGE gels and proteins were transferred 
to PVDF membranes and probed with antibodies that 
recognize EGFR.
Cell Surface Biotinylation
The analysis of EGFR internalization and recycling 
was performed as described earlier.56 Briefly, confluent 
fibroblasts were washed three times with PBS-CM 
(containing 0.2 mM CaCl2 and 2 mM MgCl2) and 
incubated for 30 min. in PBS-CM at 4°C containing the 
biotin reagent (NHS-SS-Biotin) at 0.5 mg/mL. A sample 
for each cell line was taken and frozen in RIPA buffer 
containing leupeptin (0, 1 mM) and PMSF (1 mM). After a 
first wash with PBS-CM to remove the excess of unbound 
reagent, and a second wash with MEM-BSA (MEM, 
0.6 % BSA, 20 mM Hepes-NaOH pH 7.4 and 0.35 g/L 
NaHCO3), supplemented with 100 mM glycine to quench 
the free succinimide groups, the cells were incubated at 
37ºC with 2 ng/mL EGF in MEM-BSA for 30 minutes. 
The ligand concentration used here was most suitable 
for semiquantitative determination of EGFR recycling. 
Afterwards, cells were incubated twice for two 20-minute 
periods in reduced glutathione at 50 mM in TAPs buffer 
(50 mM TAPS-NaOH pH 8.60, 100 mM NaCl and 0.2 
% BSA) and washed three times with ice cold PBS-CM. 
A sample for each cell line was taken and processed as 
above. The rest of the plates were incubated in PBS-CM 
containing iodoacetamide (5 mg/mL) for 5 minutes at 
4ºC to inactivate glutathione, and cells were washed with 
PBS-CM. EGF 2 ng/mL was added to the cells for 30 
min., Cells were washed three times with PBS-CM and a 
sample for each cell line was frozen as before. Finally, cells 
were incubated again twice for two 20-minute periods in 
reduced glutathione at 50 mM in TAPs buffer, washed 
three times with ice cold PBS-CM, and samples were 
frozen as detailed. Extracts from the different samples 
were centrifuged at 12 000 g for 10 minutes, supernatants 
were collected, biotinylated proteins were pulled-down 
with NeutrAvidin beads and analyzed by immunoblotting 
using antibodies to EGFR and the transferrin receptor. 
Immunocytochemistry, Confocal Microscopy and 
Image Analysis
Subconfluent fibroblasts were cultured for 4 hours 
on glass coverslips under high proteolysis conditions 
with protease inhibitors (1 µM pepstatin and 100 µM 
leupeptin). Cells were then fixed for 10 minutes with 4% 
paraformaldehyde in PBS-CM. After quenching of the 
free aldehyde groups, cells were permeabilized, blocked, 
and incubated at 4ºC overnight with anti-CI-MPR (1:100) 
and anti-TGN46 (1:200) to label the TGN. Secondary 
antibodies conjugated to Alexa 488 or to Alexa 595 were 
applied (1:500) for 1 hour at r.t. Slides were rinsed with 
                                                    Int Clin Neurosci J. Vol 7, No 1, Winter 2020 13
                                                                                Endo-lysosomal Alterations in JNCL Fibroblasts
journals.sbmu.ac.ir/Neurosciencehttp
PBS, mounted and observed in a confocal fluorescence 
microscope. For analysis of co-localization, cells were 
observed using a Leica TCS-SP2-AOBS confocal 
microscope using a 63X oil immersion objective of 1.4 
NA at 1024×1024 pixel resolution.
The presented images were processed using Adobe 
Photoshop software (Adobe Systems) by adjusting 
brightness and contrast levels to the same extension for all 
the experimental conditions showed in each experiment.
Statistics
The presented data for the different conditions were 
calculated as means ± S.D. of at least three independent 
experiments. GraphPad Prism version 5.0 software was 
used to perform statistical analysis. Two-tailed Student’s 
t tests was used to ascertain differences between paired 
samples and for multiple sample comparison one-way 
ANOVA was used followed by Student-Newman-Keuls 
post hoc test. The significance has been determined at 
* P<0.05, ** P <0.01 and *** P <0.005, as showed in each 
case.
Conclusion
In the past two decades, considerable progress has been 
made in understanding the function of CLN3 protein in 
the development of the JNCL neurodegenerative disease. 
Despite knowing that CLN3p is an integral transmembrane 
glycoprotein that localizes to endosomes and lysosomes5,6  
little is known about its precise function and its role in the 
development of the disease, so further investigation could 
set new molecular targets that could  prevent the onset 
of this devastating neurodegenerative disease. Our group 
published in 201326 that CLN3 cell lysosomes distinctively 
presented a statistically significantly increased pH of 0.5 
units, possibly related to the reported defects in fluid 
phase endocytosis and impairment in autophagosome 
maturation in these cells. The presented study deepens in 
the study of the consequences of increased lysosomal pH 
in CLN3 cells as opposed to CLN2 and control cells. In 
this study we analyze the regulation of the endo-lysosomal 
pathways in CLN3 cells which might be directly affected 
by the increased lysosomal pH. Clathrin-mediated 
epidermal growth factor (EGF) internalization showed to 
be reduced, possibly as consequence of impaired delivery 
of the receptor to the lysosomes, along with EGF receptor 
(EGFR) phosphorylation. Most importantly, EGFR 
lysosomal degradation was impaired and EGFR was 
rerouted to the cell membrane. We analysed the machinery 
responsible for lysosomal hydrolase transport to the 
lysosome and found increased stability of CI-MPR and 
the retromer subunits which are in charge of its retrieval 
from the endo-lysosomal system to the TGN, CI-MPR 
accumulation within the TGN and thus not progression 
into the lysosomal membranes as expected. Finally, as a 
possible consequence of these alterations in lysosomal 
enzyme transport, cathepsin L and D maturation were 
found dramatically reduced in CLN3 cells. 
Authors’ contributions
The entire manuscript was written by the author. The only author 
collected literature, designed and wrote the manuscript, edited and 
prepared manuscript for submission.
Conflict of Interest Disclosures 
The authors declare that they have no conflict of interests.
Ethical Statement
Not applicable.
Availability of Supporting Data
Supporting data is available from the author.
Funding
This work was supported by the Spanish Ministry of Science and 
Innovation (BFU2011-22630), and the Centro de Investigación 
Biomédica en Red de Enfermedades Raras (CIBERER). The funders 
had no role in study design, data collection and analysis, decision 
to publish, or preparation of the manuscript.
Acknowledgments
I thank Asunción Montaner, Nuria Mas, Erwin Knecht, Carmen 
Aguado, Jose Manuel Vidal-Donet, Marcel Vergés and Alicia 
Martínez for technical assistance. I am also grateful to Dr. Carol R. 
Haft (NIH, Bethesda, USA) and Dr. Juan Bonifacino (NIH, Bethesda, 
USA), for supplying antibodies against retromer subunits, to Dr. B. 
Hoflack (Technische Universität Dresden, Dresden, Germany) for 
the antibody against CI-MPR and to the confocal microscopy and 
the flow cytometry facilities of the Centro de Investigación Príncipe 
Felipe. 
Supplementary Materials
Supplementary file 1 contains Figure S1.
References
1. Williams RE, Mole SE. New nomenclature and classification 
scheme for the neuronal ceroid lipofuscinoses. Neurology. 
2012;79(2):183-91. doi: 10.1212/WNL.0b013e31825f0547.
2. Isolation of a novel gene underlying Batten disease, 
CLN3. The International Batten Disease Consortium. Cell. 
1995;82(6):949-57. doi: 10.1016/0092-8674(95)90274-0.
3. Kwon JM, Adams H, Rothberg PG, Augustine EF, Marshall FJ, 
Deblieck EA, et al. Quantifying physical decline in juvenile 
neuronal ceroid lipofuscinosis (Batten disease). Neurology. 
2011;77(20):1801-7. doi: 10.1212/WNL.0b013e318237f649.
4. Cooper JD. Moving towards therapies for juvenile Batten 
disease? Exp Neurol. 2008;211(2):329-31. doi: 10.1016/j.
expneurol.2008.02.016.
5. Järvelä I, Sainio M, Rantamäki T, Olkkonen VM, Carpén O, 
Peltonen L, et al. Biosynthesis and intracellular targeting 
of the CLN3 protein defective in Batten disease. Hum Mol 
Genet. 1998;7(1):85-90. doi: 10.1093/hmg/7.1.85.
6. Storch S, Pohl S, Quitsch A, Falley K, Braulke T. C-terminal 
prenylation of the CLN3 membrane glycoprotein is required 
for efficient endosomal sorting to lysosomes. Traffic. 
2007;8(4):431-44. doi: 10.1111/j.1600-0854.2007.00537.x.
7. Pearce DA, Ferea T, Nosel SA, Das B, Sherman F. Action of 
BTN1, the yeast orthologue of the gene mutated in Batten 
disease. Nat Genet. 1999;22(1):55-8. doi: 10.1038/8861.
8. Chattopadhyay S, Muzaffar NE, Sherman F, Pearce DA. The 
yeast model for batten disease: mutations in BTN1, BTN2, and 
HSP30 alter pH homeostasis. J Bacteriol. 2000;182(22):6418-
23. doi: 10.1128/jb.182.22.6418-6423.2000.
Cárcel-Trullols
Int Clin Neurosci J. Vol 7, No 1, Winter 202014 journals.sbmu.ac.ir/Neurosciencehttp
9. Gachet Y, Codlin S, Hyams JS, Mole SE. btn1, the 
Schizosaccharomyces pombe homologue of the human 
Batten disease gene CLN3, regulates vacuole homeostasis. J 
Cell Sci. 2005;118(Pt 23):5525-36. doi: 10.1242/jcs.02656.
10. Padilla-López S, Langager D, Chan CH, Pearce DA. BTN1, 
the Saccharomyces cerevisiae homolog to the human Batten 
disease gene, is involved in phospholipid distribution. Dis 
Model Mech. 2012;5(2):191-9. doi: 10.1242/dmm.008490.
11. Kama R, Robinson M, Gerst JE. Btn2, a Hook1 ortholog 
and potential Batten disease-related protein, mediates late 
endosome-Golgi protein sorting in yeast. Mol Cell Biol. 
2007;27(2):605-21. doi: 10.1128/mcb.00699-06.
12. Richardson SC, Winistorfer SC, Poupon V, Luzio JP, Piper 
RC. Mammalian late vacuole protein sorting orthologues 
participate in early endosomal fusion and interact with the 
cytoskeleton. Mol Biol Cell. 2004;15(3):1197-210. doi: 
10.1091/mbc.e03-06-0358.
13. Kama R, Kanneganti V, Ungermann C, Gerst JE. The yeast 
Batten disease orthologue Btn1 controls endosome-Golgi 
retrograde transport via SNARE assembly. J Cell Biol. 
2011;195(2):203-15. doi: 10.1083/jcb.201102115.
14. Luiro K, Yliannala K, Ahtiainen L, Maunu H, Järvelä I, Kyttälä 
A, et al. Interconnections of CLN3, Hook1 and Rab proteins 
link Batten disease to defects in the endocytic pathway. Hum 
Mol Genet. 2004;13(23):3017-27. doi: 10.1093/hmg/ddh321.
15. Uusi-Rauva K, Kyttälä A, van der Kant R, Vesa J, Tanhuanpää 
K, Neefjes J, et al. Neuronal ceroid lipofuscinosis protein 
CLN3 interacts with motor proteins and modifies location 
of late endosomal compartments. Cell Mol Life Sci. 
2012;69(12):2075-89. doi: 10.1007/s00018-011-0913-1.
16. Persaud-Sawin DA, McNamara JO, 2nd, Rylova S, Vandongen 
A, Boustany RM. A galactosylceramide binding domain 
is involved in trafficking of CLN3 from Golgi to rafts via 
recycling endosomes. Pediatr Res. 2004;56(3):449-63. doi: 
10.1203/01.pdr.0000136152.54638.95.
17. Cao Y, Staropoli JF, Biswas S, Espinola JA, MacDonald 
ME, Lee JM, et al. Distinct early molecular responses to 
mutations causing vLINCL and JNCL presage ATP synthase 
subunit C accumulation in cerebellar cells. PLoS One. 
2011;6(2):e17118. doi: 10.1371/journal.pone.0017118.
18. Appu AP, Bagh MB, Sadhukhan T, Mondal A, Casey S, 
Mukherjee AB. Cln3-mutations underlying juvenile neuronal 
ceroid lipofuscinosis cause significantly reduced levels 
of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and 
Ppt1-enzyme activity in the lysosome. J Inherit Metab Dis. 
2019;42(5):944-54. doi: 10.1002/jimd.12106.
19. Fossale E, Wolf P, Espinola JA, Lubicz-Nawrocka T, Teed 
AM, Gao H, et al. Membrane trafficking and mitochondrial 
abnormalities precede subunit c deposition in a cerebellar 
cell model of juvenile neuronal ceroid lipofuscinosis. BMC 
Neurosci. 2004;5:57. doi: 10.1186/1471-2202-5-57. 
20. Metcalf DJ, Calvi AA, Seaman M, Mitchison HM, Cutler DF. Loss 
of the Batten disease gene CLN3 prevents exit from the TGN of 
the mannose 6-phosphate receptor. Traffic. 2008;9(11):1905-
14. doi: 10.1111/j.1600-0854.2008.00807.x.
21. Braulke T, Bonifacino JS. Sorting of lysosomal proteins. 
Biochim Biophys Acta. 2009;1793(4):605-14. doi: 10.1016/j.
bbamcr.2008.10.016.
22. Qian M, Sleat DE, Zheng H, Moore D, Lobel P. Proteomics 
analysis of serum from mutant mice reveals lysosomal 
proteins selectively transported by each of the two mannose 
6-phosphate receptors. Mol Cell Proteomics. 2008;7(1):58-
70. doi: 10.1074/mcp.M700217-MCP200.
23. Kominami AE. What are the requirements for lysosomal 
degradation of subunit c of mitochondrial ATPase? IUBMB 
Life. 2002;54(2):89-90. doi: 10.1080/15216540214307.
24. Steenhuis P, Froemming J, Reinheckel T, Storch S. 
Proteolytic cleavage of the disease-related lysosomal 
membrane glycoprotein CLN7. Biochim Biophys Acta. 
2012;1822(10):1617-28. doi: 10.1016/j.bbadis.2012.05.015.
25. Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G. 
Cysteine Cathepsins in the secretory vesicle produce active 
peptides: Cathepsin L generates peptide neurotransmitters and 
cathepsin B produces beta-amyloid of Alzheimer’s disease. 
Biochim Biophys Acta. 2012;1824(1):89-104. doi: 10.1016/j.
bbapap.2011.08.015.
26. Vidal-Donet JM, Cárcel-Trullols J, Casanova B, Aguado 
C, Knecht E. Alterations in ROS activity and lysosomal pH 
account for distinct patterns of macroautophagy in LINCL and 
JNCL fibroblasts. PLoS One. 2013;8(2):e55526. doi: 10.1371/
journal.pone.0055526.
27. Marks DL, Bittman R, Pagano RE. Use of Bodipy-labeled 
sphingolipid and cholesterol analogs to examine membrane 
microdomains in cells. Histochem Cell Biol. 2008;130(5):819-
32. doi: 10.1007/s00418-008-0509-5.
28. O’Keefe E, Cuatecasas P. Cholera toxin and membrane 
gangliosides: binding and adenylate cyclase activation in 
normal and transformed cells. J Membr Biol. 1978;42(1):61-
79. doi: 10.1007/bf01870394.
29. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di 
Fiore PP. Clathrin-mediated internalization is essential for 
sustained EGFR signaling but dispensable for degradation. Dev 
Cell. 2008;15(2):209-19. doi: 10.1016/j.devcel.2008.06.012.
30. Kesarwala AH, Samrakandi MM, Piwnica-Worms D. 
Proteasome inhibition blocks ligand-induced dynamic 
processing and internalization of epidermal growth 
factor receptor via altered receptor ubiquitination and 
phosphorylation. Cancer Res. 2009;69(3):976-83. doi: 
10.1158/0008-5472.can-08-2938.
31. Arighi CN, Hartnell LM, Aguilar RC, Haft CR, Bonifacino 
JS. Role of the mammalian retromer in sorting of the cation-
independent mannose 6-phosphate receptor. J Cell Biol. 
2004;165(1):123-33. doi: 10.1083/jcb.200312055.
32. Seaman MN. Cargo-selective endosomal sorting for retrieval 
to the Golgi requires retromer. J Cell Biol. 2004;165(1):111-
22. doi: 10.1083/jcb.200312034.
33. Vergés M1. Retromer: multipurpose sorting and specialization 
in polarized transport. Int Rev Cell Mol Biol. 2008;271:153-
98. doi: 10.1016/s1937-6448(08)01204-5.
34. Banting G, Ponnambalam S. TGN38 and its orthologues: 
roles in post-TGN vesicle formation and maintenance of TGN 
morphology. Biochim Biophys Acta. 1997;1355(3):209-17. 
doi: 10.1016/s0167-4889(96)00146-2.
35. Lieu ZZ, Derby MC, Teasdale RD, Hart C, Gunn P, Gleeson 
PA. The golgin GCC88 is required for efficient retrograde 
transport of cargo from the early endosomes to the trans-Golgi 
network. Mol Biol Cell. 2007;18(12):4979-91. doi: 10.1091/
mbc.e07-06-0622.
36. Ghosh RN, Mallet WG, Soe TT, McGraw TE, Maxfield FR. An 
endocytosed TGN38 chimeric protein is delivered to the TGN 
after trafficking through the endocytic recycling compartment 
in CHO cells. J Cell Biol. 1998;142(4):923-36. doi: 10.1083/
jcb.142.4.923.
37. Lin SX, Mallet WG, Huang AY, Maxfield FR. Endocytosed 
cation-independent mannose 6-phosphate receptor traffics 
via the endocytic recycling compartment en route to the 
trans-Golgi network and a subpopulation of late endosomes. 
Mol Biol Cell. 2004;15(2):721-33. doi: 10.1091/mbc.e03-07-
0497.
38. Bonifacino JS, Rojas R. Retrograde transport from endosomes 
to the trans-Golgi network. Nat Rev Mol Cell Biol. 
2006;7(8):568-79. doi: 10.1038/nrm1985.
                                                    Int Clin Neurosci J. Vol 7, No 1, Winter 2020 15
                                                                                Endo-lysosomal Alterations in JNCL Fibroblasts
journals.sbmu.ac.ir/Neurosciencehttp
39. Sorkin A, Waters C, Overholser KA, Carpenter G. Multiple 
autophosphorylation site mutations of the epidermal growth 
factor receptor. Analysis of kinase activity and endocytosis. J 
Biol Chem. 1991;266(13):8355-62.
40. Qureshi YH, Patel VM, Berman DE, Kothiya MJ, Neufeld JL, 
Vardarajan B, et al. An Alzheimer’s Disease-Linked Loss-of-
Function CLN5 Variant Impairs Cathepsin D Maturation, 
Consistent with a Retromer Trafficking Defect. Mol Cell Biol. 
2018;38(20). doi: 10.1128/mcb.00011-18.
41. Vesa J, Chin MH, Oelgeschlager K, Isosomppi J, DellAngelica 
EC, Jalanko A, et al. Neuronal ceroid lipofuscinoses are 
connected at molecular level: interaction of CLN5 protein 
with CLN2 and CLN3. Mol Biol Cell. 2002;13(7):2410-20. 
doi: 10.1091/mbc.e02-01-0031.
42. Huber RJ, Mathavarajah S. Secretion and function of Cln5 
during the early stages of Dictyostelium development. 
Biochim Biophys Acta Mol Cell Res. 2018;1865(10):1437-50. 
doi: 10.1016/j.bbamcr.2018.07.017.
43. Maruzs T, Lőrincz P, Szatmári Z, Széplaki S, Sándor Z, Lakatos 
Z, et al. Retromer Ensures the Degradation of Autophagic 
Cargo by Maintaining Lysosome Function in Drosophila. 
Traffic. 2015;16(10):1088-107. doi: 10.1111/tra.12309.
44. Cárcel-Trullols J, Kovács AD, Pearce DA. Role of the 
Lysosomal Membrane Protein, CLN3, in the Regulation of 
Cathepsin D Activity. J Cell Biochem. 2017;118(11):3883-90. 
doi: 10.1002/jcb.26039.
45. Awano T, Katz ML, O’Brien DP, Taylor JF, Evans J, Khan 
S, et al. A mutation in the cathepsin D gene (CTSD) in 
American Bulldogs with neuronal ceroid lipofuscinosis. 
Mol Genet Metab. 2006;87(4):341-8. doi: 10.1016/j.
ymgme.2005.11.005.
46. Wavre-Shapton ST, Calvi AA, Turmaine M, Seabra MC, Cutler 
DF, Futter CE, et al. Photoreceptor phagosome processing 
defects and disturbed autophagy in retinal pigment epithelium 
of Cln3Deltaex1-6 mice modelling juvenile neuronal 
ceroid lipofuscinosis (Batten disease). Hum Mol Genet. 
2015;24(24):7060-74. doi: 10.1093/hmg/ddv406.
47. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa 
Y, et al. Cathepsin D deficiency induces lysosomal storage 
with ceroid lipofuscin in mouse CNS neurons. J Neurosci. 
2000;20(18):6898-906.
48. Canuel M, Libin Y, Morales CR. The interactomics of sortilin: 
an ancient lysosomal receptor evolving new functions. Histol 
Histopathol. 2009;24(4):481-92. doi: 10.14670/hh-24.481.
49. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, 
Bronson RT, et al. Neuronal loss and brain atrophy in mice 
lacking cathepsins B and L. Proc Natl Acad Sci U S A. 
2002;99(12):7883-8. doi: 10.1073/pnas.112632299.
50. Sevenich L, Pennacchio LA, Peters C, Reinheckel T. Human 
cathepsin L rescues the neurodegeneration and lethality 
in cathepsin B/L double-deficient mice. Biol Chem. 
2006;387(7):885-91. doi: 10.1515/bc.2006.112.
51. Xiang B, Fei X, Zhuang W, Fang Y, Qin Z, Liang Z. Cathepsin 
L is involved in 6-hydroxydopamine induced apoptosis of SH-
SY5Y neuroblastoma cells. Brain Res. 2011;1387:29-38. doi: 
10.1016/j.brainres.2011.02.092.
52. Haft CR, de la Luz Sierra M, Bafford R, Lesniak MA, Barr 
VA, Taylor SI. Human orthologs of yeast vacuolar protein 
sorting proteins Vps26, 29, and 35: assembly into multimeric 
complexes. Mol Biol Cell. 2000;11(12):4105-16. doi: 
10.1091/mbc.11.12.4105.
53. Göstring L, Chew MT, Orlova A, Höidén-Guthenberg I, 
Wennborg A, Carlsson J, et al. Quantification of internalization 
of EGFR-binding Affibody molecules: Methodological aspects. 
Int J Oncol. 2010;36(4):757-63. doi: 10.3892/ijo_00000551.
54. Lauer S, Goldstein B, Nolan RL, Nolan JP. Analysis of 
cholera toxin-ganglioside interactions by flow cytometry. 
Biochemistry. 2002;41(6):1742-51. doi: 10.1021/bi0112816.
55. Martin de Llano JJ, Andreu EJ, Pastor A, de la Guardia M, 
Knecht E. Electrothermal atomic absorption spectrometric 
diagnosis of familial hypercholesterolemia. Anal Chem. 
2000;72(11):2406-13. doi: 10.1021/ac991287p.
56. Gao YS, Hubbert CC, Yao TP. The microtubule-associated 
histone deacetylase 6 (HDAC6) regulates epidermal growth 
factor receptor (EGFR) endocytic trafficking and degradation. 
J Biol Chem. 2010;285(15):11219-26. doi: 10.1074/jbc.
M109.042754.
